B-Cell Malignancies: Oral ABBV-101 Study

We are evaluating a new oral medication for adults with B-cell malignancies to see how it affects disease activity and its safety. This study will help us understand how the medication works in the body.

>2 yearsSafety phase (I)HematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Hematology
Bordeaux, France
Centre Hospitalier Universitaire De Lille
Hematology
Loos, France
Centre Hospitalier Universitaire De Montpellier
Clinical Hematology
Montpellier, France

Sponsor: Abbvie Deutschland GmbH & Co. KG
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.